MoneyWorks4Me

Beryl Drugs informs about Outcome of Board Meeting

24 Jul 2015 Evaluate

Beryl Drugs has informed that the Board of Directors of the Company at its meeting held on July 24, 2015, has considered and approved the matter of keeping books of accounts at the place other than registered office of the Company under section 209 of the Companies Act, 2013 and the matter of alteration of articles of association under section 14 of the Companies Act, 2013.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1748.90
Dr. Reddys Labs. 1214.10
Cipla 1312.85
Lupin 1954.80
Zydus Lifesciences 1124.00
View more..